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ABSTRACT  
The stoichiometry and thermodynamic stability of vanadium(IV/V) complexes of Triapine 
and two related α(N)-heterocyclic thiosemicarbazones (TSCs) with potential antitumor 
activity have been determined by pH-potentiometry, EPR and 51V NMR spectroscopy in 30% 
(w/w) dimethyl sulfoxide/water solvent mixtures. In all cases, mono-ligand complexes in 
different protonation states were identified. Dimethylation of the terminal amino group results 
in the formation of vanadium(IV/V) complexes with considerably higher stability. Three of 
the most stable complexes were also synthesized in solid state and comprehensively 
characterized. The biological evaluation of the synthesized vanadium complexes in 
comparison to the metal-free ligands in different human cancer cell lines revealed only 
minimal influence of the metal ion. Thus, in addition the coordination ability of 
salicylaldehyde thiosemicarbazone (STSC) to vanadium(IV/V) ions was investigated. The 
exchange of the pyridine nitrogen of the α(N)-heterocyclic TSCs to a phenolate oxygen in 
STSC significantly increased the stability of the complexes in solution. Finally, this also 
resulted in increased cytotoxicity activity of a vanadium(V) complex of STSC compared to 
the metal-free ligand. 
 
* Corresponding authors. Fax: +36 62 544340; +43 1 427752680. 
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1. Introduction 
 
Thiosemicarbazones (TSCs) are Schiff bases obtained by condensation of an aldehyde 
or a ketone with a thiosemicarbazide and represent an important class of (N,S) donor ligands 
[1]. TSCs and their metal complexes are extensively investigated as they exhibit a wide range 
of pharmacologically interesting properties like anticancer, antibacterial, antiparasitic, and 
antiviral effects [2]. Especially N)-heterocyclic TSCs exert significant antitumor activity in 
vitro and in vivo [2,3]. Triapine (3-aminopyridine-2-carbaldehyde thiosemicarbazone, 3-AP, 
Chart 1) is the most prominent representative among the α(N)-pyridyl TSCs since it has 
already been tested in many phase I and II clinical trials [4]. The proposed mechanism of 
action of Triapine is based on its ability to inhibit the iron-dependent enzyme ribonucleotide 
reductase, the rate-determining enzyme in the supply of deoxyribonucleotides for DNA 
synthesis and repair [3,5]. It has been assumed that the formation of an intracellular iron 
complex of Triapine plays a crucial role in the mechanism of enzyme inhibition [6]. In this 
complex, Triapine acts as tridentate ligand and coordinates via an (Npyr,N,S
‒) donor set, 
wherein the hydrazinic-N moiety is deprotonated [3]. In general, this arrangement of the 
donor atoms for α(N)-pyridyl TSCs is also suitable for the binding of other transition metal 
ions, e.g. Cu(II), Zn(II), Ru(III), Pt(II), and Pd(II), which can result in complexes with even 
higher cytotoxicity than that of the metal-free ligands [2]. In our previous works we pointed 
out that dimethylation of the terminal nitrogen strongly enhances the cytotoxicity of α(N)-
pyridyl TSCs, especially in the absence of any NH2 group in the molecule [7]. In addition, 
terminal dimethylation results in a strong increase of the solution stability of the Fe(II/III), 
Cu(II), Zn(II), and Ga(III) complexes [7-9]. The best-known terminally dimethylated bis-
pyridyl TSC is di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), which 
demonstrated very potent anticancer activity in vivo using human xenografts in nude mice 
[10,11] and was reported to overcome multidrug-resistance in cancer cells [12].  
 In addition, to the effects of the free ligands, also a wide range of metal complexes of 
tridentate TSCs with remarkable biological effect has been reported in the literature including 
copper [13-15], platinum [16], or vanadium compounds [2,17,18]. With regards to vanadium, 
complexes of α(N)-pyridyl TSCs formed with oxovanadium(IV) and dioxovanadium(V) were 
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found to exert antibacterial, antifungal as well as antiamoebic activity [17-20]. In addition, 
insulin-enhancing properties of some V(V)O2–TSC complexes have been reported [21]. 
However, the antitumor properties of α(N)-pyridyl TSC vanadium complexes have, to the best 
of our knowledge, not been investigated so far. Moreover, despite the fact that a relatively 
large number of vanadium(IV/V) complexes of TSCs has been synthesized and characterized 
in the solid state or in solution with organic solvents [19-24], almost no information is 
available on their complex formation processes and thermodynamic stability in aqueous 
solution. Notwithstanding, the knowledge of the speciation and the most feasible chemical 
forms of a biologically active metal complex in aqueous solution, especially at physiological 
pH, can help to understand the mechanism of action and might be useful for the design of 
more effective and selective chemotherapeutics. Thus, the main aims of the present work were 
to perform a detailed solution equilibrium study on the vanadium(IV/V) complexes of 
Triapine and two terminally dimethylated derivatives (Chart 1, 3-aminopyridine-2-
carboxaldehyde N,N-dimethylthiosemicarbazone (APTSC) and pyridine-2-carboxaldehyde 
N,N-dimethylthiosemicarbazone (PTSC)), and to screen their cytotoxicity against human 
cancer cell lines. Therefore, various methods such as pH-potentiometry, UV–vis 
spectrophotometry as well as electron paramagnetic resonance (EPR) and 51V NMR 
spectroscopy were used to investigate the stoichiometry and stability of the complexes in 
solution. Additionally, several vanadium complexes were synthesized and subsequently 
characterized by means of 1H, 13C, and 51V NMR spectroscopy as well as X-ray diffraction 
studies. Finally, the obtained solution speciation data of the vanadium(IV/V) complexes 
formed with (N)-pyridyl TSCs were compared to that of salicylaldehyde thiosemicarbazone 
(STSC, Chart 1) complexes with an (O‒,N,S‒) donor set.  
 Chart 1 
 
2. Results and Discussion 
 
2.1. Solution chemistry of vanadium(IV/V) complexes of Triapine, APTSC, and PTSC  
 
2.1.1. pKa values and lipophilicity of the ligands  
 
The proton dissociation constants (pKa) of Triapine, APTSC and PTSC (Table 1) in a 
30% (w/w) DMSO/H2O solvent mixture were already determined in our previous work by 
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pH-potentiometric, UV−vis, and 1H NMR titrations [8]. In accordance to these data, the 
repetitive measurements in this study provided similar values. Noteworthy, the presence of 
DMSO was required due to the limited water solubility of the ligands as well as their 
respective vanadium complexes. The obtained pK1 can be attributed to the proton dissociation 
of the pyridinium unit and pK2 values to the deprotonation of the hydrazinic NH group of the 
thiosemicarbazide moiety. In the latter proton dissociation step, the resulting negative charge 
is mainly localized on the S atom via the thione–thiol tautomeric equilibrium (Chart 2) [8]. 
Based on the pKa values, it can be concluded that all three α-pyridyl TSCs are present in their 
neutral HL form at pH 7.4. 
 Table 1, Chart 2 
In order to characterize the lipophilic character of the ligands, distribution coefficients 
of APTSC and PTSC were determined by the traditional shake flask method at pH 7.4 
(logD7.4 values in Table 1), which represent the actual partitioning between n-octanol and 
water. As expected, the methyl groups on the terminal nitrogen of the α-pyridyl TSCs increase 
the logD7.4 value compared to that of the reference compound Triapine [25].  
 
2.1.2. Complex formation equilibria of vanadium(IV) with Triapine, APTSC, and PTSC  
 
The complex formation processes of Triapine, APTSC, and PTSC with V(IV)O were 
studied by the combined approach of pH-potentiometry, UV–vis spectrophotometry, and EPR 
spectroscopy in a 30% (w/w) DMSO/H2O solvent mixture under anaerobic conditions. The 
stoichiometries of the oxovanadium(IV) complexes and the overall stability constants 
calculated on the basis of the pH-potentiometric titrations are listed in Table 1. These studies 
revealed formation of mono-ligand complexes such as [V(IV)O(L)]+ and [V(IV)O(L)H‒1]. 
Although, other bivalent metal ions (e.g. Zn(II) and Fe(II)) form [M(LH)]2+ species as well 
[8], stability constants for this kind of V(IV)O complexes could not be calculated with 
appropriate accuracy. Complexation of Triapine with V(IV)O starts only at pH > 4 and the 
ligand is not able to protect the metal ion against the hydrolysis at a metal-to-ligand ratio of 
1:1 at pH > 6 in the 1 mM concentration range resulting in precipitation. Notably, a maximum 
of 20% of V(IV)O is bound to Triapine (at pH ~5 under this condition) representing a quite 
weak metal-binding ability of this ligand (Fig. 1a). On the contrary, complex formation 
processes with the terminally dimethylated ligands (PTSC and APTSC) start at lower pH 
values (pH ~ 2–2.5) indicating species of higher stability. In addition, the bound fraction of 
oxovanadium(IV) exceeds 90% at pH ~ 5.2 and 4.5 in the V(IV)O – APTSC and PTSC 
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systems, respectively (Figs. 1b and c). Complex formation in the V(IV)O – PTSC system was 
also monitored by UV–vis spectrophotometric titrations. Instead of the rather weak d–d 
transition bands of the complexes, the pH-dependence of the overlapping charge-transfer (CT) 
and ligand bands was followed. Differences between the absorbance values recorded in the 
presence and in the absence of the V(IV)O ions undoubtedly reveal the pH ranges of the 
complex formation followed by dissociation. This corresponds well to the expectations based 
on the concentration distribution curves calculated with the aid of the stability constants (Fig. 
S1).   
Figure 1  
In order to elucidate the actual coordination modes in solution and confirm the 
speciation model obtained by pH-potentiometry, EPR spectra were recorded at various pH 
values at room temperature (Fig. 2). In case of the V(IV)O – PTSC system, spectra could be 
recorded up to pH 9.8 using individual samples. In contrast, when titrations were performed 
with Triapine and APTSC, oxidation took place resulting in the continuous loss of the EPR 
signal at higher pH values, although the measurements were done under an argon atmosphere 
(but not under strictly anaerobic conditions). It is noteworthy, that the hydrolysis of the metal 
ion can strongly increase the sensitivity to oxidation. The two-dimensional simulation of the 
solution EPR spectra resulted in the individual isotropic EPR spectra (Fig. 2) and the isotropic 
EPR parameters of V(IV)O and the complexes [V(IV)O(L)]+ and [V(IV)O(L)H‒1] (Table 2). 
There was no indication for formation of EPR-active dinuclear or bis-ligand complexes. 
Similar g0 and A0 values were obtained for all [V(IV)O(L)]
+ complexes of the different α-
pyridyl TSCs, in which the tridentate coordination of the ligands via the (Npyr,N
2,S–) donor set 
is the most probable (Chart 3) and where the ligand possesses a deprotonated hydrazinic 
moiety. In comparison, formation of isomers and somewhat higher A0 parameters (94.7×10
-4 
cm-1 and 101×10-4 cm-1) were reported for chlorido V(IV)O-thiosemicarbazone complexes in 
a non-aqueous solvent [26]. Complexes [V(IV)O(L)H‒1] have higher g0 values and lower A0 
values compared to those of [V(IV)O(L)]+ indicating an increased ligand field due to the 
deprotonation of the coordinated water molecule. As a consequence, [V(IV)O(L)H‒1] 
complexes are considered as mixed hydroxido species [V(IV)O(L)(OH)]. Using the empirical 
additivity relationship [27,28], the average A0 value of the contribution of a thiolate, two 
aromatic nitrogen atoms (no data for imine-N) and a water molecule is 87.0×10-4 cm-1 and for 
the mixed hydroxido species 80.6×10-4 cm-1. All estimations are in good agreement with the 
measured data in Table 2.   
Figure 2, Table 2 
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In the case of the V(IV)O – PTSC system, EPR spectra were also recorded on frozen samples 
at 77 K. The calculated anisotropic EPR parameters (Table 3) and the spectra simulation for 
the [V(IV)O(L)]+ and [V(IV)O(L)H‒1] species (Fig. 3) permitted the conclusion that most 
probably two kinds of isomers with a molar ratio of ~1:6 are formed under these conditions. 
The isotropic EPR parameters of the major isomers (1) calculated by averaging the 
anisotropic values (g0,calc and A0,calc in Table 3) are similar to those of the data measured at 
room temperature showing that the structure of the complexes [V(IV)O(L)]+ and 
[V(IV)O(L)H‒1] did not change during freezing. On the other hand, the minor isomers (2) 
have fairly different anisotropic EPR parameters, which can be possibly explained by the 
octahedral “trans” (H2O: axial, PTSC: equatorial, equatorial, equatorial, H2O/OH
‒ equatorial) 
penta-coordinated square pyramidal or octahedral “trans” - octahedral “cis” (H2O: equatorial, 
PTSC: equatorial, axial, equatorial, H2O/OH
‒ equatorial) - isomerism [29], which is quite 
frequent in the case of V(IV)O species and was also observed for other V(IV)O – TSC 
complexes [24,26]. In the protonation state of VO(IV)L the octahedral “trans”, while in the 
case of complex [V(IV)OL(OH)] the penta-coordinated / octahedral “cis” forms are the most 
stable species. 
Table 3, Figure 3 
Direct comparison of stability constants and concentration distribution curves 
calculated for the V(IV)O complexes formed with the α-pyridyl TSCs (Table 1, Fig. 1) shows 
that Triapine is hardly able to form stable complexes with V(IV)O even at mM 
concentrations. In contrast, the complex stability of terminally dimethylated TSCs is distinctly 
increased. This is in good agreement with previous studies from our group on other metal ions 
[8,9].    
 
2.1.3. Complex formation equilibria of vanadium(V) with Triapine, APTSC, and PTSC 
 
As a next step, the V(V)-binding abilities of Triapine, APTSC, and PTSC were studied 
by 51V NMR spectroscopy. This method provides an excellent possibility to distinguish 
between the free V(V) species (in monomeric or different oligomeric forms) and V(V) 
complexes due to the slow ligand-exchange process with respect to the NMR time scale. 
Therefore, signals of bound and free metal ions can be seen separately (as an example, PTSC 
is shown in Figs. 4.a). However, species with the same metal-to-ligand ratio in different 
protonation states represent fast exchange processes. Thus, their signals are only shifted upon 
the (de)protonation processes. First of all, complex formation was followed at pH 7.4 in the 
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1.0 mM concentration range. No bound V(V) fractions were found in the case of Triapine as a 
consequence of the quite low vanadate affinity of this ligand. Accordingly, further 
measurements were only performed for APTSC and PTSC. 
Figure 4 
51V NMR spectra were recorded in the pH range 11.2 ‒ ~1.6 by the addition of strong 
acid to the samples, although an irreversible process was observed at pH < 5 and the 
intensities of the peaks were strongly diminished. Most probably V(V) is able to oxidize 
APTSC and PTSC in this pH range with simultaneous formation of paramagnetic V(VI)O. 
Interestingly, a similar redox reaction was already described for Fe(III) complexes of α(N)-
pyridyl TSCs, however only at pH >10 [9,30]. Solely peaks of the non-bound V(V) species 
could be observed at pH >~10, in the case of PTSC (Fig. 4.a) and APTSC, mainly in form of 
HVO4
2-. Formation of [V(V)O2(L)] was further investigated with decreasing pH and the 
position of its signal in the NMR spectra did not change down to pH ~5. In this complex, 
most probably coordination of two oxo groups and the deprotonated ligand through the 
(Npyr,N
2,S‒) donor atoms results in a distorted square-pyramidal geometry (Chart 3). This 
coordination mode was also confirmed by X-ray crystal structure analysis of solid V(V) – 
PTSC and V(V) – APTSC complexes (Section 2.2). Subsequently, the distribution of V(V) 
between bound and unbound fractions at a 1:1 metal-to-ligand ratio was calculated on the 
basis of the integrated area of the peaks for the V(V) – PTSC and APTSC systems (Fig. 4.b). 
From these values, stability constants were computed for the formation of [V(V)O2(L)] 
complexes (see Table 4 for the equilibrium processes and constants). The bound V(V) 
fraction is slightly higher for PTSC compared to APTSC (91% vs. 82%), and the bound metal 
ion fraction is higher in the case of the V(V)-containing systems compared to V(IV)O 
representing a somewhat higher stability of the V(V) complexes.    
Table 4 
   
2.2. Synthesis and characterization of vanadium(IV/V) complexes of PTSC and APTSC 
 
As a result of the solution equilibrium studies, it was concluded that Triapine is not an 
efficient chelator for vanadium(IV/V) ions. Therefore, we prepared only the vanadium 
complexes of the terminally dimethylated ligands (PTSC and APTSC) for further biological 
studies. The two metal-free ligands APTSC and PTSC were synthesized according to 
literature [7,31]. The V(V)O2-containing complexes were synthesized in methanol in 1:2 
molar ratio using the appropriate TSC ligand (HL) and the vanadium(V) precursor 
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V2O4(acac)2 (where acac = acetylacetonate) [32]. This results in formation of the orange and 
red [V(V)O2(L)] complexes of PTSC (1a) and APTSC (1b), respectively, in good yields 
(Chart 3). The green oxovanadium(IV) complex [V(IV)O(L)(acac)] of PTSC (2a) (Chart 3) 
was synthesized in ethanol in 78% yield using VO(acac)2 and the ligand in a 1:1 molar ratio. 
The 1H NMR spectrum of the V(V)O2 complexes confirmed deprotonation of the TSC 
ligands by absence of the NH proton signal of the thiosemicarbazide moiety. Furthermore, in 
contrast to the metal-free PTSC, which shows two isomeric forms [33] in DMSO-d6, the 
V(V)O2 complexes possess only one set of signals in the 
1H NMR spectra. This can be 
explained by stabilization of the ligand configuration upon coordination to the metal center. 
The 51V NMR shifts of 1a at –427.5 and 1b at –430.0 ppm measured in DMSO-d6 were in the 
expected range of this type of vanadium complexes [21]. 
Single crystals of X-ray diffraction quality of 1a were obtained after several days 
directly from the mother liquor. In contrast, crystals of 2a were produced by slow diffusion of 
ether into a solution of the complex in CH2Cl2 under argon atmosphere. Crystal data, data 
collection parameters, and structure refinement details are given in Table S1. The results of 
the X-ray diffraction studies are shown in Fig. 5 and selected bond distances and angles are 
summarized in Table 5 for 1a and 2a in comparison to the PTSC ligand [7]. For the 
vanadium(V) complex 1a (Fig. 5), the coordination polyhedron around the metal ion is  
intermediate between square-pyramidal and trigonal-bipyramidal with τ = 0.37 (τ = 1 for an 
ideal trigonal bipyramid, τ = 0 for an ideal square pyramid) [34]. The vanadium(V) is 
coordinated by one tridentate deprotonated PTSC ligand (L‒) via the pyridine nitrogen atom 
as well as the nitrogen and sulfur donors of the thiosemicarbazide moiety and two oxido 
ligands with bond length in the expected range for such type of complexes [21,24].  
Figure 5, Table 5 
In contrast, in the oxovanadium(IV) complex 2a, the coordination polyhedron 
approaches an octahedron, where one tridentate PTSC, a bidentate acac, and an oxido ligand 
is coordinated to the metal center (Fig. 5). Comparably to complex 1a, the ligand is 
deprotonated (L‒). Of note is the difference in the bond length from vanadium(IV) to the acac 
oxygen atoms with V–O1 at 1.984 Å and V–O2 at 2.155 Å. The enlongated bond length of V–
O2 can be explained by the trans influence of the oxido ligand and is in agreement with a 
similar structure with 2-acetylpyridine-4-phenylthiosemicarbazone [35]. In crystal structures 
of both, 1a and 2a, deprotonation of the PTSC ligand is accompanied with a distinct 
elongation of the C7–S bond (1a: 1.737 Å; 2a: 1.751 Å) compared to the metal-free ligand at 
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1.686 Å indicating an increased single-bond character [7]. In addition, the C7–N3 bond 
decreases from 1.373 Å to 1.325 Å in 1a and 1.334 Å in 2a, respectively. 
 
2.3. Cytotoxicity of complexes 1a, 1b, and 2a 
 
As a next step, the cytotoxicity of the novel synthesized compounds (IC50 values in 
nM) of 1a, 1b, and 2a in comparison to their metal-free ligands were measured in three 
human cancer cell lines (colon carcinoma SW480, ovarian carcinoma A2780, and epidermal 
carcinoma-derived KB-3-1 cells). Table 6 shows the IC50 values for the compounds after 72 h 
incubation measured by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium 
bromide (MTT) assay.  
Table 6 
In general, A2780 cells were found to be the most sensitive of the investigated cell 
lines, whereas SW480 and KB-3-1 cells were less affected by the compounds. In accordance 
to the literature, PTSC had IC50 values in the (low) nanomolar range, whereas, APTSC was 
active at low µM concentrations comparable to Triapine [7]. Interestingly, the sensitivity 
profile of SW480 cells was strongly different from KB-3-1 and A2780. These two cell models 
were very sensitive towards PTSC and its complexes, while in SW480 cells a distinctly 
reduced activity was observed. In contrast, APTSC and its vanadium complex showed quite 
similar activity in all three cell lines. This probably originates from differences in the mode of 
action, which were observed for PTSC compared to APTSC [36]. Despite these differences 
originating from the ligand properties, the impact of vanadium complexation was rather weak. 
Thus, only in KB-3-1a non-significant tendency for increased activity of 1a and 2a in 
comparison to the respective free ligand was observed. In contrast, 1b was slightly less active 
than APTSC in all tested cell lines. This lack of impact can most probably be explained by the 
release of the ligands due to the low solution stability of these vanadium complexes already in 
the low micro- to nanomolar concentration range.  
 
2.4. Complex formation of STSC with vanadium(IV/V) ions and cytotoxicity studies 
 
In order to investigate whether the solution stability of vanadium(IV/V) complexes of 
tridentate thiosemicarbazones and their cytotoxicity can be increased by exchange of the 
pyridyl nitrogen for a harder Lewis acid donor atom with higher affinity to the vanadium ions, 
STSC with a phenolate oxygen was chosen as a test compound (Chart 1). 
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The acid-base properties of STSC have already been studied in detail in our previous 
work [25], and the pKa values determined here are in good agreement with the published data 
(Table 1). The pK1 and pK2 values of the ligand can be attributed to deprotonation of the 
phenolic OH group as well as the hydrazinic-NH of the thiosemicarbazide moiety. 
Noteworthy, the proton dissociation constant of the azomethine nitrogen atom (pK2) of STSC 
is significantly higher compared to that of the α(N)-pyridyl TSCs. This can be explained by 
the different total charge of the ligands in the mono-protonated form: the α(N)-pyridyl TSCs 
are neutral, while STSC has one negative charge. It was found that STSC is mainly present in 
the neutral form (96% H2L; 4% HL
–) at physiological pH and its logD7.4 value [25] is 
considerably higher compared to those of the α(N)-pyridyl TSCs (Table 1). 
The V(IV)O-binding ability of STSC was studied by pH-potentiometry and EPR 
methods. The pH-potentiometric data reveal the formation of mono-ligand species: 
[V(IV)O(LH)]+, [V(IV)O(L)] as well as [V(IV)O(L)H‒1]
‒ comparably to previous data on 
complexes formed with other bivalent metal ions such as Cu(II) and Zn(II) [12]. Overall 
stability constants of the V(IV)O-STSC complexes are summarized in Table 1. Based on the 
deconvolution of the EPR spectra recorded at room temperature, a component spectrum (Fig. 
6a) and isotropic EPR parameters (Table 2) of the complex [V(IV)O(L)] could be calculated. 
Notably, data for [V(IV)O(LH)]+ and [V(IV)O(L)H‒1]
‒ could not be obtained with proper 
accuracy. This is most probably due to the low molar fraction of the protonated complex and 
the partial oxidation process in the pH range of the formation of [V(IV)O(L)H‒1]
‒. Notably, 
the g0 value of [V(IV)O(L)] is slightly higher, although A0 is in the same range, compared to 
the parameters of the corresponding complexes of Triapine, APTSC, and PTSC. It is 
noteworthy that the oxovanadium(IV) complex of salicylaldehyde semicarbazone (SSC) with 
(O‒,N,O‒) binding mode possesses significantly different EPR parameters (g0 =1.9674, A0 = 
101.4 G / 93.1×10-4 cm-1) [37]. The most feasible binding mode in the [V(IV)O(L)] complex 
of STSC is a coordination via the (O‒,N,S‒) donor set together with a deprotonated hydrazine 
moiety. This is in agreement with some X-ray crystal structures for ternary oxovanadium(IV) 
complexes of STSC or its derivatives formed with (N,N) bidentate aromatic co-ligands such 
as 1,10-phenanthroline or 2,2’-bipyridine in literature [23,38]. In the protonated 
[V(IV)O(LH)]+ species the ligand most likely coordinates via (O‒,N,S) donor atoms (with 
protonated NH group), while [V(IV)O(L)H‒1]
‒ is a mixed hydroxido complex (= 
[V(IV)O(L)(OH)]‒). 
Due to the higher ligand basicity (higher pKa values) of STSC compared to the α(N)-
pyridyl TSCs, stronger ligand effectiveness is expected at higher pH values. Indeed, the 
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increased oxovanadium(IV) binding ability of STSC over the α(N)-pyridyl TSCs is clearly 
reflected in the conditional stability constants (see log’ values calculated at pH 7.4 in Table 
1) and the higher fractions of the bound metal ion in a broader pH range including pH 7.4 (c.f. 
Figs. 6b and 1). Thus, the involvement of the phenolate oxygen into the coordination instead 
of the pyridyl nitrogen results in more favorable complex formation with V(IV)O.  
Figure 6 
Since no redox reaction was observed, the V(V) – STSC system could be monitored 
over a wider pH range by 51V NMR spectroscopy (Fig. 7.a/b) compared to the α(N)-pyridyl 
TSCs. The recorded spectra represented formation of isomeric species (1) and (2) and three 
groups of signals were identified as follows: i) unbound V(V) as HV(V)O4
2‒ and H2V(V)O4
‒; 
ii) bound V(V) as [V(V)O2(LH)] (1) and [V(V)O2(L)]
‒ (1) as well as iii) [V(V)O2(L)]
‒ (2) and 
[V(V)O2(L)H‒1]
2‒ (2) (Fig. 7.b). Based on the pH-dependence of the chemical shifts of the 
peaks, equilibrium constants were calculated for protonation of the HV(V)O4
2‒, [V(V)2(L)]
‒ 
(1) and [V(V)O2(L)H‒1]
2‒ (2) species (Table 4). For the major isomer [V(V)O2(L)]
‒ (1) 
formed between pH ~3 and ~11, our data suggest ligand coordination most probably via the 
(O‒,N2,S‒) donor set together with protonation of the N3 thiosemicarbazone nitrogen. This 
results in formation of [V(V)O2(LH)] (1) with an (O
‒,N2,S)-binding mode, which is in 
agreement with literature reports on solid phase structures for [V(V)O2(L)]
‒ and 
[V(V)O2(LH)] of STSC representing these coordination modes [22]. Based on the integrated 
areas the ratio of major and minor isomers of [V(V)O2(L)]
‒ is 6.4:1 and were detected at ‒449 
ppm and ‒577 ppm, respectively. This significant difference between the two chemical shifts 
suggests that besides the tridentate (O‒,N2,S‒)-binding mode also a rather different 
coordination mode exists. In the case of the analogous semicarbazone, SSC, a minor isomer 
was also found at a similar chemical shift (‒575.5 ppm) [37]. In this minor species, the 
chalcogen atom seems to be non-coordinated and a (O‒,N2,N4)-binding mode is feasible. 
Notably, the [V(V)O2(L)]
‒ (2) isomer has no protonated form but is able to form a mixed 
hydroxide species [V(V)O2(L)H‒1]
2‒ (2) in the basic pH range.  
Figure 7 
Representative concentration distributions curves are shown for the V(V) – STSC 
system in Fig. 8 calculated with the aid of the determined stability data (Table 4). It could be 
concluded that the species [V(V)O2(L)]
‒ (1) and (2) are predominant at neutral pH. 
Figure 8 
In order to compare the vanadium(IV/V) binding ability of the studied TSC ligands 
pM* values were also calculated at pH 7.4 (Table S2). pM* is the negative logarithm of the 
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summed equilibrium concentration of the non-bound metal ion and its hydroxido species 
under the conditions employed. According to these values the ligand effectiveness is for both 
the V(IV)O and V(V) ions in the following order: Triapine < APTSC, PTSC << STSC. Thus, 
the solution equilibrium studies clearly revealed that the exchange of the α-pyridyl nitrogen 
by a phenolate oxygen indeed resulted in formation of complexes with distinctly higher 
stability. To investigate if this is also reflected in the biological activity, a cytotoxicity test of 
the system with highest stability (V(V) with STSC) was performed in analogy to the 
biological investigations of the α-pyridyl TSCs above. In these experiments, metal-free STSC 
showed hardly any activity with IC50 value of > 100 μM in all three cell lines (KB-3-1, 
SW480 and A2780 cells). In contrast, co-incubation of STSC with NaVO3 in 1:1 ratio at pH 
7.4 (with formation of [V(V)O2(L)]
‒) was found to increase the cytotoxicity especially in 
A2780 cells to an IC50 of 27.48.2 μM (in the other two cell lines the IC50 value was still > 
100 μM). In general, it is well known that STSC possesses significantly lower 
antiproliferative activity [39] compared to the class of α(N)-pyridyl TSCs [7]. This can 
probably be explained by the fact that α(N)-pyridyl TSCs were found to be unambiguously 
more efficient chelators for Fe(II) than STSC over a wide pH range [25]. This indicates that in 
case of STSC the redox cycling of the intracellularly formed iron complexes, which is 
assumed to be crucial for the activity of thiosemicarbazones, is hampered [6].  
 
3. Conclusions  
 
In the here presented study, stoichiometry and stability of vanadium(IV/V) complexes 
formed with Triapine and two derivatives with dimethylated terminal amino groups (APTSC 
and PTSC) were studied in 30% (w/w) DMSO/H2O solvent mixture focusing on the most 
plausible species emerging at physiological pH. Stability constants and the most feasible 
coordination modes were determined by pH-potentiometry and EPR in the case of the 
oxovanadium(IV) complexes, while 51V NMR spectroscopy was applied as the main tool for 
studying the complexation of vanadium(V). Formation of only mono-ligand 
oxovanadium(IV) complexes such as [V(IV)O(L)]+ and [V(IV)O(L)(OH)] was found with 
Triapine, APTSC, and PTSC. Here, coordination of ligand most probable occurs in a 
tridentate mode via an (Npyr,N,S
–) donor set, while the hydrazinic-N is deprotonated. Triapine 
was found to be an inefficient oxovanadium(IV) binder at neutral pH, whereas the terminally 
dimethylation results in an enhancement of the complex stability. This is also true for V(V): 
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Triapine was not able to bind V(V) at pH 7.4, whereas APTSC and PTSC form [V(V)O2(L)] 
type complexes, which possessed even somewhat higher stabilities than the oxovanadium(IV) 
species.  
Subsequently, vanadium complexes of PTSC and APTSC with adequate stability at 
physiological pH were synthesized and in detail characterized followed by cell culture tests in 
human cancer cell lines. Overall, the vanadium complexes exhibited widely identical 
anticancer activity as compared to the corresponding ligands implying that the vanadium 
binding in these complexes is not sufficient to impact on the biological activity. 
In order to increase the solution stability of vanadium(IV/V)-TSC complexes, as a 
next step, STSC, a ligand containing a phenolate oxygen donor atom instead of the pyridyl 
nitrogen was investigated in our studies. The results showed that STSC forms complexes with 
oxovanadium(IV) characterized by an (O‒,N2,S)-binding mode and a protonated hydrazinic 
NH moiety ([V(IV)O(LH)]+). In addition, species with a completely deprotonated ligand 
coordinated through an (O‒,N2,S‒) donor set ([V(IV)O(L)] and [V(IV)O(L)(OH)]‒) were 
observed (with V(V) similar species were detected). The stabilities of the vanadium(IV/V) 
complexes of STSC were found to be significantly higher than that of the α(N)-pyridyl TSCs. 
Cytotoxicity measurements of a STSC–V(V) complex revealed an increase of the anticancer 
activity compared to the very low activity of the metal-free STSC ligand. In general, the 
cytotoxic activity of STSC was strongly decreased compared to α(N)-pyridyl TSCs. Thus 
STSC derivatives with higher anticancer activity e.g. terminal dimethylated derivatives will 
be investigated in subsequent studies to further increase the stability and shift the biological 
activity to the low micromolar range.  
 
4. Experimental   
 
4.1. Chemicals 
 
Triapine, PTSC, and APTSC were prepared as described previously [7,31]. STSC was 
purchased from Sigma-Aldrich and used without further purification. The exact concentration 
of the ligand stock solutions together with the proton dissociation constants were determined 
by pH-potentiometric titrations with aid of the computer program HYPERQUAD [40]. 
NaVO3, VOSO4, KOH, D2O, and DMSO-d6 were purchased from Sigma-Aldrich and HCl, 
KCl was well as DMSO from Reanal. The V(IV)O stock solution was prepared as described 
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[41] and standardized for the metal ion concentration by permanganate titration. Vanadate 
stock solution was prepared by dissolving NaVO3 in KOH solution and its concentration was 
calculated based on mass and total volume. Double distilled Milli-Q water was used for 
sample preparations. 
All solvents used for synthesis were of analytical grade and used without further 
purification. V2O4(acac)2 was synthesized according to literature procedures [32]. Elemental 
analyses were carried out on a Carlo Erba microanalyzer at the Microanalytical Laboratory of 
the University of Vienna. Electrospray ionization mass spectrometry (ESI-MS) was carried 
out with a Bruker Esquire 3000 instrument (Bruker Daltonic, Bremen, Germany). Expected 
and experimental isotope distributions were compared. UV–vis spectra for the complexes 
were recorded on a Perkin Elmer Lambda 650 UV–vis spectrophotometer using samples 
dissolved in methanol (900–210 nm). 1H and 13C one- and two-dimensional NMR spectra 
were recorded in DMSO-d6, with a Bruker Avance III 500 MHz FT-NMR spectrometer. The 
residual 1H and 13C present in DMSO-d6 were used as internal references. 
51V NMR spectra 
for the complexes were recorded in DMSO-d6 with a Bruker Avance DRX 500 MHz 
spectrometer. (Abbreviations for NMR data: py = pyridine, Cq, py = quaternary carbon of 
pyridine.) 
 
4.2. Synthesis of vanadium(IV/V) complexes of PTSC and APTSC 
 
(2-Formylpyridine N,N-dimethylthiosemicarbazonato)dioxovanadium(V), 
[V(V)O2(L)] complex of PTSC (1a): PTSC (115 mg, 0.55 mmol) was dissolved in hot 
methanol (5 mL), added to V2O4(acac)2 (100 mg, 0.27 mmol) in methanol (5 mL) and the 
mixture was stirred for 3 min. The orange precipitate formed was filtered off, washed with 
cold methanol (–20 °C) and dried in vacuo. Yield: 118 mg (74%). Anal. Calcd. for 
C9H11N4O2SV (Mr = 290.22 g/mol): C, 37.25; H, 3.82; N, 19.31; S, 11.05. Found: C, 37.15; 
H, 3.68; N, 19.11; S, 11.20. ESI-MS in methanol (positive): m/z 313, [M+Na]+; 329, [M+K]+. 
UV‒vis (methanol), max, nm (, M
 1 cm1): 221 (10015), 281 (5615), 490 (6940). 1H NMR 
(500.10 MHz, DMSO-d6): δ 8.58 (d, 1H, py,
 3JH,H = 4 Hz), 8.54 (s, 1H, HC=N), 8.24 (m, 1H, 
py), 7.87 (d, 1H, py, 3JH,H = 8 Hz), 7.57 (m, 1H, py), 3.27 (s, 6H, N(CH3)2). 
13C NMR (125.81 
MHz, DMSO-d6): δ 178.2 (C–S), 154.2 (Cq, py), 153.6 (Cpy), 146.7 (HC=N), 143.5 (Cpy), 
125.7 (Cpy), 125.4 (Cpy), 40.3 (N(CH3)2). 
51V NMR (500 MHz, DMSO-d6): −427.5 ppm. After 
a few days crystals suitable for X-ray data collection were directly obtained from the mother 
liquor. 
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(3-Amino-2-formylpyridine N,N-dimethylthiosemicarbazonato)dioxovanadium(V), 
[V(V)O2(L)] complex of APTSC (1b): APTSC (90 mg, 0.40 mmol) was suspended in 
methanol (4 mL), added to V2O4(acac)2 (73 mg, 0.20 mmol) in methanol (4 mL) and the 
mixture was stirred for 1.5 h at room temperature. The dark-red precipitate formed was 
filtered off, washed with methanol and dried in vacuo. Yield: 77 mg (63%). Anal. Calcd. for 
C9H12N5O2SV (Mr = 305.23 g/mol): C, 35.41; H, 3.96; N, 22.94; S, 11.05. Found: C, 35.54; 
H, 3.80; N, 22.63; S, 10.59. ESI-MS in methanol (positive mode): m/z 329, [M+Na]+; 344, 
[M+K]+. UV–vis (methanol), max, nm (, M
1 cm1): 257 (3030), 280 (2890), 299sh (2740), 
445 (3560). 1H NMR (500.10 MHz, DMSO-d6): δ 8.89 (s, 1H, HC=N), 7.83 (d, 1H, py,
 3JH,H 
= 5 Hz), 7.36 (dd, 1H, py, 3JH,H = 9 Hz, 
4JH,H = 1 Hz), 7.26 (dd, 1H, py, 
3JH,H = 9 Hz, 
3JH,H = 5 
Hz), 6.64 (s, 2H, NH2), 3.22 (s, 6H, N(CH3)2). 
13C NMR (125.81 MHz, DMSO-d6): δ 176.2 
(C–S), 146.2 (HC=N), 145.7 (Cq, py), 142.5 (Cpy), 135.5 (Cq, py), 128.5 (Cpy), 126.9 (Cpy), 40.3 
(N(CH3)2). 
51V NMR (500 MHz, DMSO-d6): −430.0 ppm. 
  
(Acetylacetonato(2-formylpyridine N,N-dimethylthiosemicarbazonato)oxovanadium(IV), 
[V(IV)O(L)(acac)] complex of PTSC (2a): Under an argon atmosphere, PTSC (79 mg, 0.38 
mmol) was added as a solid to a solution of VO(acac)2 (100 mg, 0.38 mmol) in ethanol (10 
mL) and the mixture was stirred for 1.5 h. The green precipitate formed was filtered off, 
washed with isopropanol, and dried in vacuo. Yield: 110 mg (78%). Anal. Calcd. for 
C14H18N4O3SV (Mr = 373.32 g/mol): C, 45.04; H, 4.86; N, 15.01; S, 8.59. Found: C, 44.86; H, 
4.98; N, 14.72; S, 8.63. ESI-MS in methanol (positive mode): m/z 396, [M+Na]+; 412, 
[M+K]+. UV‒vis (methanol), max, nm (, M
1 cm1): 268 (10740), 347sh (3955), 433 (5930). 
Crystals suitable for X-ray data collection were obtained by slow diffusion of ether into a 
solution of 2a in dichloromethane under an argon atmosphere. 
 
4.3. Crystallographic structure determination of 1a and 2a 
 
X-ray diffraction measurements were performed on a Bruker X8 APPEXII CCD 
diffractometer. A single crystal of suitable size was coated with Paratone-N oil, mounted at 
room temperature on a cryo loop and cooled under a stream of cold N2 maintained by a 
KRYOFLEX low-temperature apparatus. Crystals of 1a and 2a were positioned at 35 mm 
from the detector, and 1820/835 frames were measured, each for 30/60 s over 1° scan width. 
The data were processed using SAINT software [42]. The structures were solved by direct 
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methods and refined by full-matrix least-squares techniques. Non-hydrogen atoms were 
refined with anisotropic displacement parameters. H atoms were placed at calculated positions 
and refined as riding atoms in the subsequent least squares model refinements. The following 
software programs and computer were used: structure solution, SHELXS-97 [43]; refinement, 
SHELXL-97 [43]; molecular diagrams, ORTEP [44]; computer: Intel CoreDuo. Crystal data 
and structure refinement details for 1a and 2a are given in Table S1. Crystallographic data 
have been deposited at the Cambridge Crystallographic Data Center with numbers 
CCDC1021658 and 1021659.  
 
4.4. pH-potentiometric measurements 
 
The pH-metric measurements for determination of the protonation constants of the 
ligands and the overall stability constants of the V(IV)O complexes were carried out at 25.0 ± 
0.1 oC in DMSO:water 30:70 (w/w) as solvent and at an ionic strength of 0.10 M (KCl) in 
order to keep the activity coefficients constant. The titrations were performed with carbonate-
free KOH solution of known concentration (0.10 M). The concentrations of the base and the 
HCl were determined by pH-potentiometric titrations. An Orion 710A pH-meter equipped 
with a Metrohm combined electrode (type 6.0234.100) and a Metrohm 665 Dosimat burette 
were used for the pH-metric measurements. The electrode system was calibrated to the pH = 
−log[H+] scale in the DMSO/water solvent mixture by means of blank titrations (strong acid 
vs. strong base; HCl vs. KOH), similarly to the method suggested by Irving et al. [45] in pure 
aqueous solutions. The average water ionization constant, pKw, is 14.52 ± 0.05 in 
DMSO:water 30:70 (w/w) at 25 oC, which corresponds well to the literature [8,9,46] and 
results in pH 7.26 as neutral pH. The reproducibility of the titration points included in the 
calculations was within 0.005 pH. The pH-metric titrations were performed in the pH range 
2.0–12.6. The initial volume of the samples was 10.0 mL. The ligand concentration was 1 or 2 
mM and metal ion to ligand ratios of 1:1–1:5 were used. The accepted fitting of the titration 
curves was always less than 0.01 mL. Samples were deoxygenated by bubbling purified argon 
through them for ca. 10 min prior to the measurements. In the case of VIVO-containing 
samples, argon overpressure was used when metal ion solution was added to the samples in 
tightly closed vessels, which were prior completely deoxygenated by bubbling a stream of 
purified argon through them for ca. 20 min. Argon was also passed over the solutions during 
the titrations. 
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The protonation constants of the ligands were determined with the computer program 
HYPERQUAD [40], and PSEQUAD [47] was utilized to establish the stoichiometry of the 
complexes and to calculate the stability constants (log MpLqHr)) using the literature data for 
V(IV)O hydroxido complexes [48]. It is noteworthy that hydrolysis constants of V(IV)O 
hydroxido complexes are not known in the literature for the applied solvent mixture. 
MpLqHr) is defined for the general equilibrium pM + qL + rH MpLqHr as  (MpLqHr) = 
[MpLqHr]/[M]
p[L]q[H]r, where M denotes the metal ion (V(IV)O) and L the completely 
deprotonated ligands. In all calculations, exclusively titration data were used from 
experiments in which no precipitate was visible in the reaction mixture. 
 
4.5. UV–vis spectrophotometric and 51V NMR measurements 
 
A Hewlett Packard 8452A diode array spectrophotometer was used to record the UV–
vis spectra in the interval 260–820 nm. The path length was 1 cm. Protonation and stability 
constants and the individual spectra of the species were calculated by the computer program 
PSEQUAD [47]. The spectrophotometric titrations were performed on samples of the pure 
TSCs or with V(IV)O; the concentration of ligand was 50 or 63 M and the metal-to-ligand 
ratios were 1:1 and 1:2 over the pH range between 2 and 12.6 at an ionic strength of 0.10 M 
KCl in 30% (w/w) DMSO/H2O at 25.0 ± 0.1 
oC. For V(IV)O samples, spectra were recorded 
under anaerobic conditions.  
51V NMR studies were carried out on a Bruker Avance DRX500 instrument and a 
spectral window of 760 ppm, a 90◦ pulse angle and an acquisition time of 0.65 s with a 
relaxation delay of 0.5 s and a pulse width of 7 ms were used. V(V)OCl3 was used as an 
external reference. The TSCs were dissolved in 30% (v/v) DMSO 60% H2O and 10% D2O at 
25 oC in a concentration of 1.0 or 1.8 mM and the V(V)O2-to-ligand ratios were 1:1 or 1:1.1. 
Samples contained 0.10 M KCl. Overall stability or stepwise constants for the complex 
formation equilibria were determined with the aid of the computer program PSEQUAD [47] 
on the basis of the integral values and chemical shifts using the literature data for the 
vanadates (H+/V(V)) [49].  
 
4.6. Determination of the distribution coefficient (D) 
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D7.4 values of PTSC and APTSC were determined by the traditional shake flask 
method in n-octanol/buffered aqueous solution at 7.40 (HEPES, 0.01 M) at 25.0 ± 0.2 oC. 
Measurements and calculations were performed similarly as we described previously for 
Triapine and STSC [25]. 
 
4.7. EPR measurements and deconvolution of the spectra 
 
All continuous-wave (CW) EPR spectra were recorded with a BRUKER EleXsys 
E500 spectrometer (microwave frequency 9.81 GHz, microwave power 10 mW, modulation 
amplitude 5 G, modulation frequency 100 kHz). EPR spectra were recorded at 1.0 mM of 
V(IV)O and the metal-to-ligand ratios were 1:1, 1:2, 1:2 and 1:4 for STSC, APTSC, PTSC, 
and Triapine, respectively, between pH ~ 2 – 8 in 30 % (w/w) DMSO/H2O mixture at an ionic 
strength of 0.10 M KCl. For the V(IV)O ‒ Triapine, APTSC, PTSC and STSC systems 4, 4, 8 
and 5 isotropic EPR spectra were recorded at room temperature. At higher pH the EPR signal 
disappeared possibly because of V(IV)O oxidation, although titrations were carried out under 
argon atmosphere. Oxidation could be excluded more efficiently in the case of PTSC and 
spectra of individual samples could be recorded up to pH 9.8.   
At certain pH values, 0.10 mL of samples were taken out of the solutions into quartz 
EPR tubes and were measured individually in a Dewar containing liquid nitrogen (at 77 K). 
KOH solution was added to the stock solution to change the pH which was measured with an 
Orion 710A pH-meter equipped with a Metrohm combined electrode (type 6.0234.100).  
Series of V(IV)O CW-EPR spectra recorded at 25 oC were simulated by the „two-
dimensional” method using the 2D_EPR program [50]. The go, and Ao
V (I = 7/2) 
oxovanadium(IV) hyperfine coupling parameters were taken into account to describe each 
component curve. The relaxation parameters, , , and , defined the line widths through the 
equation MI =  + MI + MI
2, where MI denotes the magnetic quantum number of the 
paramagnetic metal ions.  
The anisotropic EPR spectra recorded at 77 K were analyzed individually with the 
EPR program [51]. For the V(IV)O complexes gǀǀ, g┴ axial g-tensor and Aǀǀ
V, A┴
V axial 
hyperfine tensor were taken into consideration. The following expressions are valid for the g 
values in the case of a dxy ground state and an axial symmetry: 
 
                                    and                                   .      
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Here, α, β, and γ are the vanadium dx
2
-y
2, dxy, and dxz,yz orbital populations, ξ is the spin–orbit 
constant, ΔE(x2−y2) and ΔE(xz,yz) are the energy differences between the dx
2
-y
2, dxz,yz excited 
states, respectively, and the dxy ground state. 
For each spectrum, the noise-corrected regression parameter (Rj for the j
th spectrum) 
was derived from the average square deviation (SQD) between experimental and calculated 
intensities. For the series of spectra, the fit is characterized by the overall regression 
coefficient R, calculated from the overall average SQD. The details of the statistical analysis 
were published previously [51]. The hyperfine and superhyperfine coupling constants and the 
relaxation parameters were obtained in field units (Gauss = 10-4 T) and were calculated to 10-4 
cm-1 by the correspondence of A [10-4cm-1]  0.4668643 g A [G]. 
 
4.8. Cell lines and culture conditions 
 
The following human cell lines were used in this study: the colon carcinoma cell line 
SW480 (from American Type Culture Collection, Manassas, VA), the ovarian carcinoma cell 
line A2780 (from Sigma-Aldrich) and the epidermal carcinoma-derived cell line KB-3-1 
(generously donated by D.W. Shen, Bethesda, USA). All cells were grown in RMPI 1640 
supplemented with 10% fetal bovine serum (FCS), with the exception of SW480 cells with 
were cultivated in minimal essential medium with 10% FCS. Cultures were regularly checked 
for Mycoplasma contamination.  
 
4.9. MTT assays 
 
To determine cell viability, cells were plated (2×103 cells in 100 µL/well) in 96-well 
plates and allowed to recover for 24 h. Stock solutions (in DMSO) of the test compounds 
(APTSC, PTSC, STSC, 1a, 2a, 1b) were diluted in complete culture medium and added to the 
plates (100 μL/well). The maximum DMSO content did not exceed 0.5%. Stock solution of 
the V(V)–STSC complex was prepared by addition of NaVO3 in water to STSC in DMSO at a 
1:1 metal-to-ligand ratio, followed by subsequent dilution with cell culture medium. After 72 
h drug treatment, the proportion of viable cells was determined by the colorimetric MTT 
microculture assay following the manufacturer’s recommendations (EZ4U, Biomedica, 
Vienna, Austria).  
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Abbreviations 
1a   (2-formylpyridine N,N-dimethylthiosemicarbazonato)dioxovanadium(V) 
1b   (3-amino-2-formylpyridine N,N-
dimethylthiosemicarbazonato)dioxovanadium(V) 
2a   (acetylacetonato(2-formylpyridine N,N-
dimethylthiosemicarbazonato)oxovanadium(IV) 
acac  acetylacetonate 
APTSC  3-aminopyridine-2-carboxaldehyde N,N-dimethylthiosemicarbazone 
CT  charge transfer 
CW   continuous-wave 
d  chemical shift 
D7.4  distribution coefficient at pH 7.4 
DMSO dimethyl sulfoxide 
Dp44mT di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone 
  molar absorptivity  
ESI-MS electrospray ionization mass spectrometry 
FCS  fetal bovine serum 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
MTT  3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide 
PTSC  pyridine-2-carboxaldehyde N,N-dimethylthiosemicarbazone 
SQD  average square deviation 
SSC  salicylaldehyde semicarbazone 
STSC  salicylaldehyde thiosemicarbazone 
TSC  thiosemicarbazone 
Triapine 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 
UV–vis UV–visible 
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Table 1 Proton dissociation constants (pKa) and logD7.4 values of the studied TSC ligands as 
well as overall (logβ), stepwise and conditional stability constants for their V(IV)O complexes 
{T = 25.0˚C, I = 0.10 M (KCl) in 30% (w/w) DMSO/H2O}.
a 
a Uncertainties (SD) of the last digits are shown in parentheses determined for the TSCs studied in 
the present work. Charges of the metal complexes are omitted for clarity. 
b Taken from [8].  
c Taken from [25]. 
d Conditional stability constants at pH = 7.4; ’ =   β [V(IV)O(L)] × (1 + β [V(IV)O(L)H-1] / [H
+] / 
β [V(IV)O(L)]) / (1 + [H+]×HL + [H
+]2×H2L). 
e at pH = 7.4; cV(IV)O = 1.0 mM; V(IV)O:L =1:1. 
  
 Triapine APTSC PTSC STSC 
pK1 3.92
b 4.31b 3.38b 8.89c 
pK2 10.78
b 10.29b 10.54b 12.59c 
logD7.4 +0.85
c +1.30(8) +1.11(15) +1.74c 
logβ [V(IV)O(LH)] – – – 20.55(2) 
logβ [V(IV)O(L)] 8.50(8) 10.30(4) 10.83(2) 16.67(1) 
logβ [V(IV)O(L)H-1] 3.21(9) 4.14(12) 4.74(5) 9.79(1) 
pK [V(IV)O(L)] 5.29 6.16 6.09 6.88 
fitting  parameter (mL) 4.90×10-3 3.25×10-3 2.90×10-3 3.08×10-3 
logK’ [V(IV)O(L)]d 7.23 8.67 9.02 10.61 
predominant complexe ([V(IV)O2(OH)5]) [V(IV)O(LH-1)] [V(IV)O(LH-1)] [V(IV)O(LH-1)] 
25 
 
Table 2 Isotropic EPR parameters obtained for the V(IV)O – TSC complexes calculated from 
the two-dimensional simulation of EPR spectra {T = 25.0˚C, I = 0.10 M (KCl) in 30% (w/w) 
DMSO/H2O}.
a 
a Uncertainties (SD) of the last digits are shown in parentheses determined in the present 
work. 
 
Table 3 Anisotropic EPR parameters obtained for the V(IV)O – PTSC complexes {T = 77 K, 
I = 0.10 M (KCl) in 30% (w/w) DMSO/H2O}.
a 
 gǀǀ g┴ Aǁ 
/ ×10-4cm-1 
A
┴ 
/ ×10-4cm-1 
g
o
,
calc
b A
o
,
calc 
c 
/ ×10-4cm-1  
V(IV)O2+  1.9325 1.9743 179.7 67.5 1.9604 104.9 
[V(IV)O(L)]+
 
(1)  1.9525 1.9801 158.2 54.4 1.9709 89.0 
[V(IV)O(L)]+ (2)  1.9470 1.9788 164.5 59.6 1.9672 94.6 
[V(IV)O(L)H-1 ] (1)  1.9546 1.9801 153.6 50.5 1.9716 84.9 
[V(IV)O(L)H-1 ] (2) 1.9683 1.9823 143.6 45.6 1.9776 78.3 
a The experimental error was  ±0.001 for gǀǀ, ±0.0005 for g┴, ± 0.5 ×10
-4 cm-1 for Aǁ , and ± 0.2 
×10-4 cm-1 for A┴ . 
b g0,calc = (gǀǀ+2g┴)/3. 
 c A0,calc = (Aǀǀ+2A┴)/3. 
  
ligand species g0 A0  / ×10
-4cm-1  / G  / G  / G 
– V(IV)O2+ 1.9616(2) 104.5(2) 18.7(1) 3.5(1) 1.8(1) 
Triapine [V(IV)O(L)]+ 1.9703(8) 87.8(8) 23(2) 5(1) 2.8(3) 
Triapine [V(IV)O(L)H-1] 1.972(2) 82.9(4) 26(7) 3(2) 3(1) 
APTSC [V(IV)O(L)]+ 1.9709(9) 87.4(1) 23(3) 5(2) 3.3(1) 
APTSC [V(IV)O(L)H-1] 1.971(2) 79.1(3) 26(7) 3(2) 3(1) 
PTSC [V(IV)O(L)]+ 1.9702(2) 88.7(6) 19(3) 4(1) 2.3(5) 
PTSC [V(IV)O(L)H-1] 1.9711(4) 83.1(6) 19(7) 3(2) 2(1) 
STSC [V(IV)O(L)] 1.9717(7) 87.6(7) 21(1) 3(1) 2.0(3) 
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Table 4 Stability and protonation constants determined for the species formed in the V(V)O2 
– TSC systems and their chemical shifts (d (51V)) {T = 25.0˚C, I = 0.10 M (KCl) in 30% (v/v) 
DMSO, 60% (v/v) H2O, 10% (v/v) D2O}.
a 
ligand               equilibrium constant 
‒ HVO4
2‒ + H+   H2VO4
‒           
 
‒561 ppm              ‒536 ppm 
logK = 9.36(2) 
APTSC H2VO4
‒ +HL + H+  [VO2(L)] + 2 H2O 
                                ‒416 ppm 
log = 3.08(3) 
PTSC H2VO4
‒ +HL  + H+  [VO2(L)] + 2 H2O 
                               ‒421 ppm 
log = 3.34(3) 
STSC [VO2(L)]
‒ (1) + H+  [VO2(LH)]  
  ‒449 ppm                       ‒502 ppm 
logK = 3.56(1) 
STSC [VO2(L)H‒1]
2‒ + H+    [VO2(L)]
‒ (2) 
  ‒539 ppm                          ‒577 ppm 
logK = 9.95(2) 
STSC H2VO4
‒ +H2L  [VO2(L)]
‒ (1) + 2 H2O log = 5.42(5) 
STSC H2VO4
‒ +H2L  [VO2(L)]
‒ (2) + 2 H2O log = 4.57(5) 
a Uncertainties (SD) of the last digits are shown in parentheses. 
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Table 5 Selected bond lengths, angles and torsions for 1a, 2a and PTSCa 
a Uncertainties (SD) of the last digits are shown in parentheses. 
b Taken from [7].  
  
 1a 2a PTSC
b 
V(IV)–O1  [Ǻ]  1.984(1)  
V(IV)–O2 [Ǻ]  2.155(1)  
V(IV)–O3 [Ǻ]  1.608(1)  
V(V)–O1 [Ǻ] 1.608(2)   
V(V)–O2 [Ǻ] 1.617(2)   
V–S1 [Ǻ] 2.3725(8) 2.4026(6)  
V–N1 [Ǻ] 2.105(2) 2.150(1)  
V–N2 [Ǻ] 2.149(2) 2.074(1)  
    
S1–C7 [Ǻ] 1.737(3) 1.751(2) 1.686(1) 
N2–N3 [Ǻ] 1.355(3) 1.365(2) 1.359(1) 
N2–C6 [Ǻ] 1.291(3) 1.294(2) 1.294(1) 
N3–C7 [Ǻ] 1.325(3) 1.334(2) 1.373(1) 
N4–C7 [Ǻ] 1.328(4) 1.341(2) 1.342(1) 
C5–C6 [Ǻ] 1.439(4) 1.453(2) 1.466(2) 
    
S–V–N2 [deg] 76.91(6) 79.08(4)  
N1–V–N2 [deg] 74.67(8) 77.42(5)  
S–V–N1 [deg] 151.38(7) 154.07(4)  
N2–V–O1 [deg] 121.2(1) 163.89(5)  
N2–V–O2 [deg] 129.1(1)   
N1–V–O1 [deg] 97.3(1)   
N1–V–O2 [deg] 97.4(1)   
O2–V–O3 [deg]  171.86(5)  
    
C6–N2–N3–C7 [deg] –178.7(2) –171.3(1) 177.6(1) 
N2–N3–C7–S [deg] –0.2(3) 4.0(2) –4.9(1) 
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Table 6 In vitro cytotoxicity (IC50 values in nM) of 1a, 1b, and 2a in comparison to their 
metal-free ligands were measured in human cancer cell lines.  
 KB-3-1 SW480 A2780 
1a  6737 >500 3.3 9 
2a  6034 3304 2.5 4 
PTSC  925 31013 2.5 3 
1b  10007 7004 60017 
APTSC  75030 4003 3406 
Triapine 280020a 40050b   N/A 
a Taken from [36]. 
b Taken from [14]. 
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 Figures/Charts and Legends 
 
      
 
Chart 1. Ligands used in this study: Triapine (3-AP) = 3-aminopyridine-2-carboxaldehyde 
thiosemicarbazone; APTSC = 3-aminopyridine-2-carboxaldehyde N,N-dimethylthiosemicarbazone; 
PTSC = pyridine-2-carboxaldehyde N,N-dimethylthiosemicarbazone; STSC = salicylaldehyde 
thiosemicarbazone.  
 
 
 
Chart 2. Tautomerism of thiosemicarbazones. 
 
 
Chart 3. Structures of the synthesized complexes 1a, 1b and 2a. 
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Fig. 1. Representative concentration distribution diagrams for V(IV)O complexes formed in the 
V(IV)O – Triapine (a), APTSC (b) and PTSC (c) systems plotted against the pH calculated on the 
basis of the pH-potentiometric results. {V(IV)O:L = 1:1; cligand = 2.0 mM; T = 25.0 ˚C, I = 0.10 M 
(KCl) in 30% (w/w) DMSO/H2O.} Dashed lines indicate the pH range where significant amounts of 
hydrolyzed V(IV)O species are formed. 
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Fig. 2. Experimental (black) and simulated (red) isotropic EPR spectra recorded for the V(IV)O – 
Triapine (a), APTSC (b) and PTSC (c) systems together with the calculated component EPR spectra of 
the various species. Spectral intensities have been normalized for better comparison. {cligand = 1.0 mM; 
V(IV)O:L = 1:2, 1:2 and 1:4 for APTSC, PTSC and Triapine, respectively; T = 25.0˚C, I = 0.10 M 
(KCl) in 30% (w/w) DMSO/H2O.} 
 
 
Fig. 3. Calculated component anisotropic EPR spectra of V(IV)O and various isomeric species formed 
in the V(IV)O – PTSC system. {T = 77 K, I = 0.10 M (KCl) in 30% (w/w) DMSO/H2O.} 
 
 
 
3000 3300 3600 3900 4200
Magnetic field (G)
2.71
4.56
5.46
5.87
pH
VO
2+
VOL
VOLH
-1
 
3000 3300 3600 3900 4200
Magnetic field (G)
VOLH
-1
VOL
VO
2+
pH
7.83
5.78
3.47
2.52
 
3000 3300 3600 3900 4200
Magnetic field (G)
2.46
3.42
5.58
7.67
VO
2+
VOL
VOLH
-1
pH
(a) (b) (c)
2.11
2.83
4.94
5.92
6.69
7.87
8.81
9.77.
.
.
.
.
V(IV)O
[V(IV)OL]+
[V(IV)OLH-1]
V(IV)O
[V(IV)OL]+
[V(IV)OLH-1]
V(IV)O
[V(IV)OL]+
[V(IV)OLH-1]
2700 3000 3300 3600 3900 4200
Magnetic field (G)
V(IV)O
[V(IV)OL]+ (2)
[V(IV)OL]+ (1)
[V(IV)OLH-1] (2)
[V(IV)OLH-1] (1)
32 
 
 
Fig. 4. 51V NMR spectra recorded for the V(V) – PTSC system at various pH values (a) and molar 
fractions of the non-bound vanadate (as the sum of the fractions of HVO4
2-/ H2VO4
- / HV2O7
3-/ 
H2V2O7
2- / V4O12
4-; empty circles) and bound V(V) (filled circles) for PTSC (black symbols) and 
APTSC (grey symbols) from the integrated area of the 51V NMR signals (b). {cV(V) = 1.0 mM; V(V):L 
= 1:1; T = 25.0˚C, I = 0.10 M (KCl) in 30% (v/v) DMSO, 60% (v/v) H2O, 10% (v/v) D2O.} 
 
 
 
Fig. 5. ORTEP view of [V(V)O2(L)] complex of PTSC (1a) and [V(IV)O(L)(acac)] complex of PTSC 
(2a) with thermal ellipsoids at 50% probability level. Selected bond distances and angles are 
summarized in Table S2. 
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Fig. 6. Experimental (black) and simulated (red) isotropic EPR spectra recorded for the V(IV)O – 
STSC system together with the calculated component EPR spectra of the various species with 
normalized spectral intensities for better comparison (a), and representative concentration distribution 
diagrams for V(IV)O complexes formed in the same system plotted against the pH calculated on the 
basis of the pH-potentiometric results (b) {cligand = 1.0 mM; V(IV)O:L = 1:1; T = 25.0˚C, I = 0.10 M 
(KCl) in 30% (w/w) DMSO/H2O}.   
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Fig. 7. 51V NMR spectra recorded for the V(V) – STSC system at various pH values (a) and chemical 
shifts of the various groups of species plotted against the pH (b). : [V(V)O2LH]   [V(V)O2L]
‒ (1) 
+ H+; ○: [H2V(V)O4]
‒  [HV(V)O4]
2‒ + H+; □: [V(V)O2L]
‒ (2)  [V(V)O2L(OH)]
2‒ + H+. {cV(V) 
= 1.8 mM; V(V):L = 1:1.1; T = 25.0˚C, I = 0.10 M (KCl) in 30% (v/v) DMSO, 60% (v/v) H2O, 10% 
(v/v) D2O.} 
 
 
Fig. 8. Concentration distribution curves for the V(V) – STSC system.  {cV(V) = 1.8 mM; V(V):L = 
1:1.1; T = 25.0˚C, I = 0.10 M (KCl) in 30% (v/v) DMSO, 60% (v/v) H2O, 10% (v/v) D2O.} 
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